SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nephroplus Healthcare Services Pvt Ltd Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 0 NSE: | Hospital & Healthcare Services | Small Cap

BSE Share Price
Not Listed

Nephroplus Healthcare Services Pvt Ltd

BSE: 0 NSE:
Key Metrics
Market Cap
₹0 Cr.
P/E Ratio
0.00
Price to Book (P/B)
0.00
Price to Sales (P/S)
0.00
EV/EBITDA
0.00
Return on Capital Employed (ROCE)
-51.78%
Current Price
₹0
Return on Equity (ROE)
-74.59%
Return on Assets (ROA)
-41.62%
Operating Profit Margin
-39.5%
Net Profit Margin
-53.24%
Gross Profit Margin
-38.3%
Book Value per Share
₹0
Sales Growth (YoY)
41.1%
Sales Growth (3 Years)
35.02%
Operating Profit Growth (1 Year)
NA%
Operating Profit Growth (3 Years)
N/A%
Net Profit Growth (1 Year)
NA%
52-Week Low / High
₹0 / 0
Net Profit Growth (3 Years)
N/A%
Dividend Yield
0.00%
Promoter Holding
%
Pledged shares (%)
of Promoter's holding (%)
%

DeciZen - make an informed investing decision on Nephroplus Healthcar

Based on:

M-Cap below 100cr DeciZen not available

Nephroplus Healthcare Services Pvt stock performance

Key Ratios
mw4me loader

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18TTM
ROCE % 0%-44.7%0%-42.8%-37.6%-30.6%-41.5%-33.6%-47.1%-51.8%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00.1038.712.416.420.728.740.440
Sales YoY Gr.-NA-100%NA185.5%43%32.8%25.7%38.8%41.1%-
Adj EPS 0-1.90-13.9-26.5-20.9-29.3-24-30.7-33.20
YoY Gr.-NANANANANANANANANA-
BVPS (₹) 5.87.13.754.566.545.762.138.154350
Adj Net
Profit
0-0.80-8.7-16.5-13-18.3-15-19.9-21.50
Cash Flow from Ops. 00000-11.3-12.8-13.8-13.3-17-
Debt/CF from Ops. 0000000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA36.1%35%41.1%
Adj EPS NANANANA
BVPS22.2%-12.1%-17.4%-35.1%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18TTM
Return on
Equity %
0-45.20-41.2-37.6-30.6-41.6-33.8-47.2-51.90
Op. Profit
Mgn %
0-566.40-296.3-157-82.4-87.5-58-53.6-39.5NAN
Net Profit
Mgn %
0-688.90-286.2-191.2-105.2-111.2-72.6-69.4-53.20
Debt to
Equity
0.80.100000000-
Working Cap
Days
01,06802422622642202262011760
Cash Conv.
Cycle
015044977735428350

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 40.4 -
BVPS (₹) 0 -
Reserves (₹ Cr.) 16 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) 10
Industry PE 86.1

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Nephroplus Healthcar - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Sales00.1103.038.6512.3716.4320.6528.6640.44
Operating Expenses + 00.76011.9922.2422.5730.8032.6344.0656.42
Manufacturing Costs00.060001.111.257.6410.5315.70
Material Costs00.0801.473.414.315.135.718.0511.34
Employee Cost 00.1002.617.096.7911.6011.0613.3818.31
Other Costs 00.5107.9011.7310.3612.828.2312.1011.06
Operating Profit 0-0.650-8.96-13.59-10.20-14.37-11.98-15.41-15.98
Operating Profit Margin (%) --566.0%--296.0%-157.0%-82.4%-87.5%-58.0%-53.8%-39.5%
Other Income + 00.0101.860.801.230.701.400.450.55
Exceptional Items 000-0.37000000
Interest 00.010000.020.050.070.100.06
Depreciation 00.1401.453.754.034.544.334.876.04
Profit Before Tax 0-0.780-8.93-16.54-13.02-18.26-14.99-19.92-21.53
Tax 000-0.01000000
Profit After Tax 0-0.780-8.92-16.54-13.02-18.26-14.99-19.92-21.53
PAT Margin (%) --688.0%--294.0%-191.0%-105.0%-111.0%-72.6%-69.5%-53.2%
Adjusted EPS (₹)0.0-1.90.0-14.3-26.5-20.9-29.3-24.0-30.7-33.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18

Equity and Liabilities

Shareholders Fund + 0.013.472.3539.0449.023648.7433.7547.2435.71
Share Capital 0.014.255.3111.2413.7413.7416.2416.2418.7219.48
Reserves 0-0.78-2.9627.8035.2922.2632.5017.5228.5316.23
Debt +00.440.040000000
Long Term Debt00.440.040000000
Short Term Debt0000000000
Minority Interest0000000000
Trade Payables00.160.550.620.650.571.094.236.547.43
Others Liabilities 00.150.983.433.392.565.565.353.952.60
Total Liabilities 0.014.213.9143.0953.0739.1355.3843.3357.7245.75

Fixed Assets

Net Fixed Assets +0.012.932.7716.9620.2218.5715.1714.0519.4621.97
Gross Block0.013.073.4319.0726.0428.4229.4731.6840.9049.58
Accumulated Depreciation00.140.662.105.829.8514.3017.6421.4427.61
CWIP 0002.330.520.840.622.791.600.51
Investments 0000000000
Inventories00.030.050.200.460.700.731.551.282.47
Trade Receivables00.020.120.342.102.863.483.995.928.91
Cash Equivalents 00.180.1220.4323.2510.8928.6311.9219.721.20
Others Assets 01.060.852.836.515.276.759.039.7510.69
Total Assets 0.014.213.9143.0953.0739.1355.3843.3357.7245.75

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Cash Flow From Operating Activity + 00-11.31-12.84-13.79-13.28-17.03
PBT 00-13.02-18.26-14.99-19.92-21.53
Adjustment 004.518.023.886.486.92
Changes in Working Capital 00-2.79-2.64-2.33-0.12-3.91
Tax Paid 0000-0.350.271.49
Cash Flow From Investing Activity + 0000-6.92-5.12-8.51
Capex 0000-4.51-9.49-8.81
Net Investments 0000-43.990.01
Others 00001.590.380.29
Cash Flow From Financing Activity + 00-1.0530.57030.207.02
Net Proceeds from Shares 000310010
Net Proceeds from Borrowing 0000000
Interest Paid 0000000
Dividend Paid 0000000
Others 00-1.05-0.43030.20-2.98
Net Cash Flow 00-12.3617.73-20.7111.80-18.52

Finance Ratio

PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Ratios
ROE (%)0-51.660-49.52-43.78-37.18-54.31-47.95-67.78-74.59
ROCE (%)0-44.650-42.76-37.57-30.58-41.46-33.59-47.08-51.78
Asset Turnover Ratio00.0500.130.180.270.350.420.570.78
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days058028517370666367
Inventory Days085015141716201817
Payable Days03500145685259170244225

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Nephroplus Healthcare Services Pvt Ltd FAQs

The current trading price of Nephroplus Healthcar on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Nephroplus Healthcar stood at ₹0.00 Cr

The latest P/E ratio of Nephroplus Healthcar as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Nephroplus Healthcar as of 31-Dec-1969 is 0.00.

The 52-week high of Nephroplus Healthcar is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nephroplus Healthcar is ₹40.44 ( Cr.) .

About Nephroplus Healthcare Services Pvt Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×